Vyera Pharmaceuticals

Fermata Pharma Inc. is a privately held company based in New York, NY, dedicated to developing innovative treatments for a range of diseases including Alzheimer's disease, lung cancer, an orphan disease, lymphangio-leiomyomatosis, and COVID-19. The company's research efforts also extend to exploring the potential benefits of shingles vaccination in reducing the risk of Alzheimer's and Parkinson's Disease, as presented at the National Vaccine Advisory Committee Meeting in Washington, D.C. on September 22, 2022.Generated from the website

Lauren Sciences LLC, based in New York, NY, is a pioneering company that addresses the significant challenge in treating central nervous system (CNS) diseases. Their breakthrough V-Smart Platform enables the delivery of therapeutic agents, including nucleic acids, antibodies, biologics, and small molecules, to the brain, overcoming the blood-brain barrier (BBB) non-invasively and with triple-targeted precision. With a robust pipeline of V-Smart Nanomedicines in development for various CNS indications such as ALS, PD, AD, Neuro-HIV, GBM, and Chronic Pain, Lauren Sciences aims to significantly improve patients' lives by providing access to therapeutic agents that were previously unavailable due to BBB limitations, pharmacokinetics, bioavailability, toxicity, invasive treatments, or the preference for oral administration.Generated from the website

Bayer HealthCare Pharmaceuticals is the U.S.-based pharmaceuticals operation of Bayer HealthCare, an affiliate of Bayer. Bayer HealthCare Pharmaceuticals works for the development, manufacturing and marketing of drugs and treatment products to improve the human health. It operates through various business units, including women's health care, diagnostic imaging, general medicine, oncology, and hematology and neurology. It focuses on diagnosing, preventing and treating a variety of diseases and health conditions. Some the company s products include Cipro, Ciproxin, Avelox, Magnevist, Eovist, Ultravist, VistaTrak and Feridex I.V. It conducts research studies that focus on the development of treatment options and therapies for solid tumors and hematological malignancies.